HK1165955A1 - -二甲基苯基硫基 苯基 哌嗪的提純 - Google Patents
-二甲基苯基硫基 苯基 哌嗪的提純Info
- Publication number
- HK1165955A1 HK1165955A1 HK12106536.4A HK12106536A HK1165955A1 HK 1165955 A1 HK1165955 A1 HK 1165955A1 HK 12106536 A HK12106536 A HK 12106536A HK 1165955 A1 HK1165955 A1 HK 1165955A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- dimethylphenylsulfanyl
- piperazine
- purification
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200900223 | 2009-02-17 | ||
| PCT/DK2010/050039 WO2010094285A1 (en) | 2009-02-17 | 2010-02-16 | Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1165955A1 true HK1165955A1 (zh) | 2012-10-12 |
Family
ID=42101395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK12106536.4A HK1165955A1 (zh) | 2009-02-17 | 2012-07-04 | -二甲基苯基硫基 苯基 哌嗪的提純 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8598348B2 (zh) |
| EP (1) | EP2398785B1 (zh) |
| JP (1) | JP5738774B2 (zh) |
| KR (1) | KR101639833B1 (zh) |
| CN (1) | CN102317272B (zh) |
| AR (1) | AR075436A1 (zh) |
| AU (1) | AU2010214956B2 (zh) |
| BR (1) | BRPI1006975B1 (zh) |
| CA (1) | CA2751498C (zh) |
| CL (1) | CL2011001992A1 (zh) |
| CO (1) | CO6400224A2 (zh) |
| DK (1) | DK2398785T3 (zh) |
| EA (1) | EA020473B1 (zh) |
| ES (1) | ES2441079T3 (zh) |
| HK (1) | HK1165955A1 (zh) |
| HR (1) | HRP20131236T1 (zh) |
| IL (1) | IL214178A (zh) |
| MX (1) | MX2011008661A (zh) |
| NZ (1) | NZ594658A (zh) |
| PL (1) | PL2398785T3 (zh) |
| PT (1) | PT2398785E (zh) |
| RS (1) | RS53074B (zh) |
| SG (1) | SG173735A1 (zh) |
| SI (1) | SI2398785T1 (zh) |
| SM (1) | SMT201400010B (zh) |
| TW (1) | TW201033181A (zh) |
| WO (1) | WO2010094285A1 (zh) |
| ZA (1) | ZA201105992B (zh) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014016322B8 (pt) * | 2012-01-03 | 2020-12-01 | H Lundbeck As | processo para a preparação de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina |
| CN104797566B (zh) * | 2012-09-19 | 2017-07-07 | 桑多斯股份公司 | 沃替西汀氢溴酸盐的新结晶形式 |
| CA2893468C (en) | 2012-12-13 | 2021-01-12 | H. Lundbeck A/S | Use of vortioxetine and donepezil in the treatment of cognitive impairment |
| PT2958903T (pt) * | 2013-02-22 | 2017-05-26 | H Lundbeck As | Processo para manufatura de vortioxetina |
| US20160200698A1 (en) * | 2013-09-12 | 2016-07-14 | Hangzhou Pushai Pharmaceutical Technology Co., Ltd | Vortioxetine salt and crystal thereof, their preparation method, pharmaceutical compositions and usage |
| US10414741B2 (en) | 2013-09-30 | 2019-09-17 | Cadila Healthcare Limited | Amorphous vortioxetine and salts thereof |
| EP2878596A1 (en) * | 2013-11-29 | 2015-06-03 | LEK Pharmaceuticals d.d. | Synthesis of vortioxetine via (2-(piperazine-1-yl)phenyl)lithium intermediates |
| CN103788020B (zh) * | 2014-01-22 | 2015-11-04 | 苏州明锐医药科技有限公司 | 沃替西汀的制备方法 |
| CN103788019B (zh) * | 2014-01-22 | 2015-10-07 | 苏州明锐医药科技有限公司 | 沃替西汀的制备方法 |
| US9822086B2 (en) | 2014-01-31 | 2017-11-21 | Egis Gyogyszergyar Zrt. | Process for the preparation of vortioxetine salts |
| CN104059030B (zh) * | 2014-05-30 | 2016-05-04 | 镇江圣安医药有限公司 | [(苯硫烷基)-苯基]哌嗪的衍生物及其药物组合物和用途 |
| CN105218482B (zh) * | 2014-06-24 | 2018-04-06 | 杭州和泽医药科技有限公司 | 沃替西汀氢溴酸盐β晶型的制备方法 |
| US9687484B2 (en) | 2014-07-18 | 2017-06-27 | Dipharma Francis S.R.L. | Crystalline forms of an antidepressant compound |
| WO2016079751A2 (en) | 2014-11-17 | 2016-05-26 | Megafine Pharma (P) Ltd. | A process for preparation of vortioxetine and polymorphs thereof |
| CN105669594A (zh) * | 2014-11-19 | 2016-06-15 | 康普药业股份有限公司 | 抗抑郁症药1-[2-(2,4-二甲基苯基硫基)苯基]哌嗪的制备方法 |
| CN105801517A (zh) * | 2014-12-30 | 2016-07-27 | 上海奥博生物医药技术有限公司 | 一种沃替西汀氢溴酸盐新晶型及其制备方法 |
| WO2016125190A2 (en) | 2015-02-04 | 2016-08-11 | Mylan Laboratories Limited | Novel crystalline forms of vortioxetine, premixes, and processes for the preparation thereof |
| EP3274330A1 (en) | 2015-03-26 | 2018-01-31 | Cipla Limited | Method for making serotonin reuptake inhibitors |
| CN105439980B (zh) * | 2015-05-08 | 2017-10-24 | 北京北陆药业股份有限公司 | 一种氢溴酸沃替西汀一仲丁醇合物及其制备方法 |
| CN105367515B (zh) * | 2015-05-08 | 2017-10-27 | 北京北陆药业股份有限公司 | 一种氢溴酸沃替西汀α晶型的制备方法 |
| CN106316985B (zh) * | 2015-06-18 | 2021-11-09 | 郑州深蓝海生物医药科技有限公司 | 一种β型高效氢溴酸沃替西汀转晶方法 |
| US20190194154A1 (en) * | 2016-01-20 | 2019-06-27 | Amneal Pharmaceuticals Company Gmbh | Polymorphic Forms Of Vortioxetine Hydrobromide Tert-Butanolate |
| KR20190025556A (ko) | 2016-07-01 | 2019-03-11 | 하. 룬드벡 아크티에셀스카브 | 항우울 효과의 신속한 개시를 위한 보티옥세틴 투여 요법 |
| US10519121B2 (en) | 2016-12-30 | 2019-12-31 | Apicore Us Llc | Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts |
| JP7121751B2 (ja) * | 2017-04-25 | 2022-08-18 | ハー・ルンドベック・アクチエゼルスカベット | ボルチオキセチンＨＢｒ α型を製造するための方法 |
| CN108017595A (zh) * | 2017-12-20 | 2018-05-11 | 安徽源久源科技有限公司 | 一种1-[2-(2,5-二甲基苯硫基)苯基]哌嗪的制备方法 |
| CN112125868B (zh) * | 2020-09-25 | 2021-08-03 | 中山万远新药研发有限公司 | 一种氢溴酸伏硫西汀晶型及其制备方法、组合物与用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB852974A (en) | 1958-04-17 | 1960-11-02 | Parke Davis & Co | Ethers and means for producing the same |
| FR2186237B1 (zh) | 1972-05-03 | 1975-10-31 | Synthelabo | |
| US5576460A (en) | 1994-07-27 | 1996-11-19 | Massachusetts Institute Of Technology | Preparation of arylamines |
| UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| BR122020011920A2 (pt) * | 2006-06-16 | 2020-08-25 | Lundbeck & Co As H | composto, composição farmacêutica, método para tratar uma doença, uso de um composto, e processos para a preparação de um composto, e para a fabricação de um composto |
| EA016054B1 (ru) * | 2006-06-16 | 2012-01-30 | Х. Лундбекк А/С | Кристаллические формы 4-[2-(4-метилфенилсульфанил)фенил] пиперидина с объединенным ингибированием повторного поглощения серотонина и норадреналина для лечения невропатической боли |
| TW200848411A (en) * | 2007-03-20 | 2008-12-16 | Lundbeck & Co As H | Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine |
-
2010
- 2010-02-04 TW TW099103300A patent/TW201033181A/zh unknown
- 2010-02-16 PT PT107048902T patent/PT2398785E/pt unknown
- 2010-02-16 KR KR1020117019067A patent/KR101639833B1/ko active IP Right Grant
- 2010-02-16 US US13/148,088 patent/US8598348B2/en active Active
- 2010-02-16 SI SI201030444T patent/SI2398785T1/sl unknown
- 2010-02-16 JP JP2011549435A patent/JP5738774B2/ja active Active
- 2010-02-16 AU AU2010214956A patent/AU2010214956B2/en active Active
- 2010-02-16 MX MX2011008661A patent/MX2011008661A/es active IP Right Grant
- 2010-02-16 NZ NZ594658A patent/NZ594658A/xx not_active IP Right Cessation
- 2010-02-16 PL PL10704890T patent/PL2398785T3/pl unknown
- 2010-02-16 SG SG2011059227A patent/SG173735A1/en unknown
- 2010-02-16 DK DK10704890.2T patent/DK2398785T3/da active
- 2010-02-16 CN CN201080007947.5A patent/CN102317272B/zh active Active
- 2010-02-16 BR BRPI1006975-5A patent/BRPI1006975B1/pt active IP Right Grant
- 2010-02-16 WO PCT/DK2010/050039 patent/WO2010094285A1/en active Application Filing
- 2010-02-16 ES ES10704890.2T patent/ES2441079T3/es active Active
- 2010-02-16 EP EP10704890.2A patent/EP2398785B1/en active Active
- 2010-02-16 AR ARP100100441A patent/AR075436A1/es not_active Application Discontinuation
- 2010-02-16 RS RS20130554A patent/RS53074B/en unknown
- 2010-02-16 CA CA2751498A patent/CA2751498C/en not_active Expired - Fee Related
- 2010-02-16 EA EA201171065A patent/EA020473B1/ru not_active IP Right Cessation
-
2011
- 2011-07-19 IL IL214178A patent/IL214178A/en active IP Right Grant
- 2011-08-05 CO CO11099111A patent/CO6400224A2/es not_active Application Discontinuation
- 2011-08-16 ZA ZA2011/05992A patent/ZA201105992B/en unknown
- 2011-08-16 CL CL2011001992A patent/CL2011001992A1/es unknown
-
2012
- 2012-07-04 HK HK12106536.4A patent/HK1165955A1/zh unknown
-
2013
- 2013-12-30 HR HRP20131236AT patent/HRP20131236T1/hr unknown
-
2014
- 2014-01-22 SM SM201400010T patent/SMT201400010B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1165955A1 (zh) | -二甲基苯基硫基 苯基 哌嗪的提純 | |
| IL238068A0 (en) | New therapeutic uses of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine | |
| ZA201107731B (en) | Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine | |
| HRP20130819T1 (en) | New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine | |
| ZA200907511B (en) | Novel piperazine salts as D3/D2 antagonists | |
| IL244059A0 (en) | Phenoxymethyl heterocyclic compounds | |
| IL202666A0 (en) | Substituted piperazines | |
| ZA201201653B (en) | Novel azaheterocyclic compounds | |
| AP3583A (en) | Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine | |
| GB0919817D0 (en) | Heterocyclic compounds | |
| GB0919816D0 (en) | Heterocyclic compounds |